Loryjean
On 10/28/09, Julia <sunsprout@gmail.com> wrote:
>
>
> It was interesting looking up Stephen Barrett, MD. Searching him on
> Mercola.com brings up an article. Evidently there is more to the
> story.
> Personally, he doesn't hold a candle to Dr. Hill and the wonderful
> scientists that we have on the doTerra science board. I am so
> impressed with their professionalism and willingness to teach us with
> kindness. Amen to your comment Monica!
>
> Julia
>
>
> On Oct 28, 11:29 am, jcm...@aol.com wrote:
>> You might find this very interesting....and follow the link at the end as
>> well,
>> Jan In Florida <><
>>
>> 10.28.2009
>>
>> Dr Mercola, a MD, states on
>> an email I received from a friend:
>>
>> "A study published in
>> the Lancet just found that influenza vaccination was NOT
>> associated with a reduced risk of pneumonia in older people. Why is this
>> important? Because 35,000 of the 36,000 "flu" deaths the government claims
>> happen each year are actually caused by diseases like pneumonia, and NOT
>> the
>> flu
>>
>> ·
>> Giving young children
>> flu shots appeared to have no impact on flu-related doctor visits or
>> hospitalizations during two recent flu seasons, according to a study
>> published
>> in the October issue of the Archives of Pediatric &
>> Adolescent Medicine. This link opens up Dr
>> Mercola's website.
>>
>> ·
>> The flu vaccine is no
>> more effective for children than a placebo, according to a large-scale,
>> systematic review of 51 studies,
>> published in the Cochrane Database of Systematic
>> Reviews. Dr Mercola is plagiarizing this information. See the actual
>> study abstract below.
>>
>> ·
>> NO studies have conclusively proven that flu shots prevent flu-related
>> deaths among
>> the elderly. For this statement, Dr
>> Mercola is quoting his own website.
>>
>> ·
>> A study published in the Lancet just found that influenza vaccination was
>> NOT
>> associated with a reduced risk of pneumonia in older people. Why is this
>> important? Because 35,000 of the 36,000 "flu" deaths the government claims
>> happen
>> each year are actually caused by diseases like pneumonia, and NOT the flu.
>> Again, DrMercola is plagiarizing the information,
>> as pneumonia is a consequence of influenza, as the medical profession
>> knows.
>>
>> ·
>> Research published in
>> the American Journal of Respiratory and
>> Critical Care Medicine
>> also confirms that there has been no decrease in deaths from influenza and
>> pneumonia, despite the fact that vaccination coverage among the elderly
>> has
>> increased from 15 percent in 1980 to 65 percent now. Please read the
>> original study abstract below. The
>> red highlights are mine.
>>
>> For even more information, studies and
>> statistics about the flu shot, please review this previous article."
>>
>> My (Jeannie
>> Boyle) investigation reveals the following, using the links supplied by Dr
>> Mercola: (red highlights are added by me)
>>
>> Vaccines
>> for preventing influenza in healthy children.Smith
>> S, Demicheli V,
>> Di Pietrantonj C,
>> Harnden AR,
>> Jefferson T,
>> Matheson NJ,
>> Rivetti A.
>>
>> Oxford University, Institute of Health
>> Sciences, Old Road Headington, Oxford, UK, OX3 7LF.
>> sue.sm...@public-health.oxford.ac.uk
>> BACKGROUND: In children and adults the consequences of influenza are
>> mainly absences from school and work, however the risk of complications is
>> greatest in children and people over 65 years old. OBJECTIVES: To appraise
>> all
>> comparative studies evaluating the effects of influenza vaccines in
>> healthy
>> children; assess vaccine efficacy (prevention of confirmed influenza) and
>> effectiveness (prevention of influenza-like illness) and document adverse
>> events associated with receiving influenza vaccines. SEARCH STRATEGY: We
>> searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The
>> Cochrane Library Issue 1, 2005); OLD MEDLINE (1966 to 1969); MEDLINE (1969
>> to
>> December 2004); EMBASE (1974 to December 2004); Biological Abstracts (1969
>> to
>> December 2004); and Science Citation Index (1974 to December 2004). We
>> wrote to
>> vaccine manufacturers and a number of corresponding authors of studies in
>> the
>> review. SELECTION CRITERIA: Any randomised controlled trials (RCTs),
>> cohort and
>> case-control studies of any influenza vaccine in healthy children under 16
>> years
>> old. DATA COLLECTION AND ANALYSIS: Two authors independently assessed
>> trial
>> quality and extracted data. MAIN RESULTS: Fifty-one studies involving
>> 263,987
>> children were included. Seventeen papers were translated from Russian.
>> Fourteen
>> RCTs and 11 cohort studies were included in the analysis of vaccine
>> efficacy
>> and effectiveness. From RCTs, live vaccines showed an efficacy of 79% (95%
>> confidence interval (CI) 48% to 92%) and an effectiveness of 33% (95% CI
>> 28% to
>> 38%) in children older than two years compared with placebo or no
>> intervention.
>> Inactivated vaccines had a lower efficacy of 59% (95% CI 41% to 71%) than
>> live
>> vaccines but similar effectiveness: 36% (95% CI 24% to 46%). In children
>> under
>> two, the efficacy of inactivated vaccine was similar to placebo.
>> Thirty-four
>> reports containing safety outcomes were included, 22 including live
>> vaccines, 8
>> inactivated vaccines and 4 both types. The most commonly presented
>> short-term
>> outcomes were temperature and local reactions. The variability in design
>> of studies
>> and presentation of data was such that meta-analysis of safety outcome
>> data was
>> not feasible. AUTHORS' CONCLUSIONS: Influenza
>> vaccines are efficacious in children older than two years but little
>> evidence
>> is available for children under two. There
>> was a marked difference between vaccine efficacy and effectiveness. That
>> no
>> safety comparisons could be carried out emphasizes the need for
>> standardisation
>> of methods and presentation of vaccine safety data in future studies. It
>> was
>> surprising to find only one study of inactivated vaccine in children under
>> two
>> years, given recent recommendations to vaccinate healthy children from six
>> months old in the USA and Canada. If immunisation in children is to be
>> recommended as public-health policy, large-scale studies assessing
>> important
>> outcomes and directly comparing vaccine types are urgently required.
>>
>> PMID: 16437500 [PubMed - indexed
>> for MEDLINE
>>
>> The Dr Oz link displays:
>> "PAGE NOT FOUND" –Here Dr Mercola is providing a dead-end
>> link.
>>
>> ______________________________________________________________________________
>>
>>
>> Am J
>> Respir Crit Care Med. 2008 Sep 1;178(5):527-33. Epub 2008 Jun 12.
>> Mortality reduction with
>> influenza vaccine in patients with pneumonia outside "flu" season:
>> pleiotropic benefits or residual confounding? Eurich
>> DT, Marrie
>> TJ, Johnstone
>> J, Majumdar
>> SR. Department of Public Health Sciences, School of Public Health,
>> University of Alberta, 13-103 Clinical Sciences Bldg., Edmonton, AB, T6G
>> 2G3
>> Canada. deur...@ualberta.ca Comment in: Am J
>> Respir Crit Care Med. 2008 Sep 1;178(5):439-40.
>>
>> RATIONALE: Observational studies
>> suggest a 50% mortality reduction for older patients receiving influenza
>> vaccination; some deem this magnitude of benefit implausible and invoke
>> confounding by the "healthy user effect" as an alternate explanation.
>> OBJECTIVES: To evaluate unrecognized confounding by hypothesizing the
>> presence
>> of a 50% mortality reduction with vaccination for patients with pneumonia
>> outside of
>> influenza season. METHODS: Clinical, laboratory, and functional data were
>> prospectively collected on 1,813 adults with community-acquired pneumonia
>> admitted to six hospitals outside of influenza season in the Capital
>> Health
>> region (AB, Canada). Vaccination status was ascertained by interview and
>> chart
>> review. Outcome
>> was in-hospital mortality. Influenza-vaccinated patients were
>> matched to a nonvaccinated control using propensity scores, and then
>> multivariable regression was used to determine the independent association
>> between vaccination and mortality. MEASUREMENTS AND MAIN RESULTS: The
>> cohort
>> consisted of 352 vaccine recipients and 352 matched control subjects. Most
>> (85%) patients were 65 years or older, 29% had severe pneumonia, and 12%
>> died. Influenza
>> vaccination was associated with a 51% mortality reduction (28 of 352 [8%]
>> died
>> vs. 53 of 352 [15%] control subjects; unadjusted odds ratio [OR],
>> 0.49; 95% confidence interval [CI], 0.30-0.79; P = 0.004) outside
>> influenza
>> season. Adjustment for age, sex, and comorbidities did not alter these
>> findings
>> (adjusted OR, 0.45; 95% CI, 0.27-0.76). More complete adjustment for
>> confounding (e.g., functional and socioeconomic status) markedly
>> attenuated
>> these benefits and their statistical significance (adjusted OR, 0.81; 95%
>> CI,
>> 0.35-1.85; P = 0.61). CONCLUSIONS: The 51% reduction in mortality with
>> vaccination initially observed in patients with pneumonia who did not have
>> influenza was most likely a result of confounding. Previous observational
>> studies may have overestimated mortality benefits of influenza
>> vaccination.
>>
>> PMID: 18556629 [PubMed - indexed for
>> MEDLINE]
>>
>> Please have a look at the link below:
>>
>> http://www.quackwatch.org/04ConsumerEducation/nonrecperiodicals.html
> >
>
--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google
Groups "Everything doTERRA" group.
To post to this group, send email to everythingdoterra@googlegroups.com
To unsubscribe from this group, send email to
everythingdoterra+unsubscribe@googlegroups.com
For more options, visit this group at
http://www.everythingdoterra.com
-~----------~----~----~----~------~----~------~--~---
No comments:
Post a Comment